Mucomyst and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mucomyst (acetylcysteine) and Lantus (insulin glargine recombinant). Common drug interactions include depression among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Mucomyst and Lantus. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Mucomyst?

Mucomyst has active ingredients of acetylcysteine. eHealthMe is studying from 1,835 Mucomyst users. Check the latest studies of Mucomyst.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

77 people who take Mucomyst and Lantus together, and have interactions are studied.

What are the common drug interactions of Mucomyst and Lantus, by gender? *:

female:

Depression
Fear
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
Pneumonia
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Emotional distress
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Renal injury (kidney injury)
Hypotension (abnormally low blood pressure)

male:

Sepsis (a severe blood infection that can lead to organ failure and death)
Dyspnoea (difficult or laboured respiration)
Hypertension (high blood pressure)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Acidosis (build-up of carbon dioxide in the blood)
Acute respiratory distress syndrome
Anaemia (lack of blood)
Bandaemia (excess of band cells (immature white blood cells) released by the bone marrow into the blood)
Bronchial haemorrhage (bleeding in bronchia)

What are the common drug interactions of Mucomyst and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Cough
Increased bronchial secretion
Pulmonary function test decreased

20-29:

Face oedema (swelling of face)
Laryngeal discomfort
Lip oedema (swelling of lip)
Tongue oedema (swelling of tongue)

30-39:

Acidosis (build-up of carbon dioxide in the blood)
Acute respiratory distress syndrome
Anaemia (lack of blood)
Asthenia (weakness)
Bandaemia (excess of band cells (immature white blood cells) released by the bone marrow into the blood)
Blood creatinine increased
Blood urea increased
Bronchial haemorrhage (bleeding in bronchia)
Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
Constipation

40-49:

Chest pain
Nausea (feeling of having an urge to vomit)
Renal failure acute (rapid kidney dysfunction)
Sepsis (a severe blood infection that can lead to organ failure and death)
Abdominal pain
Abdominal pain upper
Abdominal wound dehiscence (abdominal wound ruptures)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block second degree (heart block second degree)
Cardiac failure congestive

50-59:

Renal failure (kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Injury
Arteriosclerosis (thickening and hardening of arteries)
Bradycardia (abnormally slow heart action)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure congestive
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dyspnoea (difficult or laboured respiration)
Hypotension (abnormally low blood pressure)

60+:

Renal failure acute (rapid kidney dysfunction)
Anxiety
Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
Acute respiratory failure
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Arthralgia (joint pain)
Chronic obstructive airways disease
Fear
Injury
Multi-organ failure (multisystem organ failure)

What are the existing conditions these people have? *

Pain: 17 people, 22.08%
High Blood Pressure: 17 people, 22.08%
Cystic Fibrosis (disease of the secretary glands): 11 people, 14.29%
Asthma: 10 people, 12.99%
Wheezing (a high-pitched whistling sound made while you breath): 9 people, 11.69%
Inflammation: 9 people, 11.69%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 9 people, 11.69%
Blood Glucose Decreased: 9 people, 11.69%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 9 people, 11.69%
Cough: 9 people, 11.69%

* Approximation only. Some reports may have incomplete information.

Do you take Mucomyst and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously